These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 1461870

  • 1. The renal effects of dopamine and dobutamine in stable chronic heart failure.
    Good J, Frost G, Oakley CM, Cleland JG.
    Postgrad Med J; 1992; 68 Suppl 2():S7-11. PubMed ID: 1461870
    [Abstract] [Full Text] [Related]

  • 2. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
    De Vecchis R, Pucciarelli G, Nocerino L, Cocozza M, Setaro A, Torre G, Imperatore F.
    Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199
    [Abstract] [Full Text] [Related]

  • 3. Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans.
    Olsen NV.
    Dan Med Bull; 1998 Jun; 45(3):282-97. PubMed ID: 9675540
    [Abstract] [Full Text] [Related]

  • 4. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M.
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [Abstract] [Full Text] [Related]

  • 5. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.
    Cotter G, Weissgarten J, Metzkor E, Moshkovitz Y, Litinski I, Tavori U, Perry C, Zaidenstein R, Golik A.
    Clin Pharmacol Ther; 1997 Aug; 62(2):187-93. PubMed ID: 9284855
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Comparison of effects of low-dose dopamine and dobutamine in patients with nonoliguric renal failure].
    Li MQ, Shi ZX, Xu JY, Zhang Z, Lu F, Li L.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Jan; 18(1):51-3. PubMed ID: 16464390
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S, Warfield KT, Wood CM, Miller WL.
    Am J Cardiol; 2006 Dec 15; 98(12):1627-30. PubMed ID: 17145223
    [Abstract] [Full Text] [Related]

  • 12. Neurohormonal activation, the renal dopaminergic system and sodium handling in patients with severe heart failure under vasodilator therapy.
    Ferreira A, Bettencourt P, Dias P, Pestana M, Serrão P, Soares-da-Silva P, Cerqueira-Gomes M.
    Clin Sci (Lond); 2001 May 15; 100(5):557-66. PubMed ID: 11294697
    [Abstract] [Full Text] [Related]

  • 13. Comparative effects of combined dopamine and nitroprusside versus dobutamine and nitroprusside infusions for computer-controlled management of low-output cardiac failure after open heart surgery.
    Pomer S, Elert O, Sarai K, Satter P.
    Int J Clin Pharmacol Ther Toxicol; 1986 Feb 15; 24(2):77-81. PubMed ID: 3957495
    [Abstract] [Full Text] [Related]

  • 14. Aquaretic effect of lixivaptan, an oral, non-peptide, selective V2 receptor vasopressin antagonist, in New York Heart Association functional class II and III chronic heart failure patients.
    Abraham WT, Shamshirsaz AA, McFann K, Oren RM, Schrier RW.
    J Am Coll Cardiol; 2006 Apr 18; 47(8):1615-21. PubMed ID: 16630999
    [Abstract] [Full Text] [Related]

  • 15. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
    Wang DJ, Dowling TC, Meadows D, Ayala T, Marshall J, Minshall S, Greenberg N, Thattassery E, Fisher ML, Rao K, Gottlieb SS.
    Circulation; 2004 Sep 21; 110(12):1620-5. PubMed ID: 15337695
    [Abstract] [Full Text] [Related]

  • 16. The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance.
    Givertz MM, Massie BM, Fields TK, Pearson LL, Dittrich HC, CKI-201 and CKI-202 Investigators.
    J Am Coll Cardiol; 2007 Oct 16; 50(16):1551-60. PubMed ID: 17936154
    [Abstract] [Full Text] [Related]

  • 17. [Effects of dopamine and dobutamine on renal function and urinary excretion of prostaglandin E2 in elderly postoperative patients].
    Niiya S, Fukusaki M, Nakamura T, Miyoshi H, Ogata K, Miyako M.
    Masui; 2001 Feb 16; 50(2):122-6. PubMed ID: 11244764
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT, Charles CJ, Nicholls MG, Richards AM.
    Circ Heart Fail; 2009 Nov 16; 2(6):532-40. PubMed ID: 19919977
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.